| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
2,301
|
435
|
2,474
| | Cost of Revenue | 95 | 50 | 269 | | |
Gross Profit
|
2,206
|
385
|
2,205
| |
|
Operating Expenses |
|
Research Development | 16,889 | 44,182 | 39,706 |
|
Selling General and Administrative | 8,230 | 6,981 | 5,940 |
|
Non Recurring |
-
|
-
|
-
|
|
Others | 259 | 148 | 168 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(23,172)
|
(50,927)
|
(43,608)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (4,320) | (0) | (1,900) |
|
Earnings Before Interest And Taxes | (27,492) | (50,927) | (45,508) |
|
Interest Expense | 348 | 682 | 688 |
|
Income Before Tax | (27,840) | (51,609) | (46,196) |
|
Income Tax Expense | (122) |
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (27,718) | (51,609) | (46,196) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(27,718)
|
(51,609)
|
(46,196)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(27,718)
|
(51,609)
|
(46,196)
|
|